España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Verona Pharma
VRNA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$57.30
0.06
0.10%
At close: -
$57.00
-0.30
-0.52%
After Hours: Jan 31, 7:50 PM EDT
Get Report
Comment
Verona Pharma (VRNA) Forecast
News
Earnings
Verona Pharma (VRNA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Verona Pharma (NASDAQ:VRNA) Stock
Verona Pharma Stock (NASDAQ: VRNA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 21, 2025
HC Wainwright & Co. Reiterates Buy on Verona ...
Benzinga Newsdesk
Thursday, January 16, 2025
Verona Pharma's Options Frenzy: What You Need to Know
Benzinga Insights
Friday, January 10, 2025
Roth MKM Initiates Coverage On Verona Pharma ...
Benzinga Newsdesk
Wednesday, January 08, 2025
Wells Fargo Maintains Overweight on Verona Ph...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Verona Ph...
Benzinga Newsdesk
Tuesday, January 07, 2025
Verona Pharma shares are trading higher follo...
Benzinga Newsdesk
Verona Pharma Sees Q4 Sales Of $36M For Ohtuv...
Benzinga Newsdesk
Tuesday, November 05, 2024
Wells Fargo Maintains Overweight on Verona Ph...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Verona P...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Verona Pha...
Benzinga Newsdesk
Monday, November 04, 2024
Verona Pharma shares are trading higher after...
Benzinga Newsdesk
Verona Pharma Q3 2024 GAAP EPS $(0.07) Beats ...
Benzinga Newsdesk
Wednesday, October 09, 2024
Truist Securities Maintains Buy on Verona Pha...
Benzinga Newsdesk
Thursday, October 03, 2024
Verona Pharma shares are trading higher after...
Benzinga Newsdesk
Wells Fargo Initiates Coverage On Verona Phar...
Benzinga Newsdesk
Tuesday, October 01, 2024
HC Wainwright & Co. Reiterates Buy on Verona ...
Benzinga Newsdesk
Monday, September 30, 2024
Verona Pharma to Present Phase 3 COPD Study R...
Benzinga Newsdesk
Tuesday, September 17, 2024
HC Wainwright & Co. Reiterates Buy on Verona ...
Benzinga Newsdesk
Verona Pharma And Ritedose Partner To Deliver...
Benzinga Newsdesk
Wednesday, September 11, 2024
Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Verona ...
Benzinga Newsdesk
Friday, September 06, 2024
GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With Amgen/AstraZeneca's Drug
Vandana Singh
Thursday, September 05, 2024
Verona Pharma To Present Oral Presentation An...
Benzinga Newsdesk
Wednesday, August 14, 2024
Top 3 Health Care Stocks That May Crash In August
Avi Kapoor
Tuesday, August 13, 2024
9 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Thursday, August 08, 2024
Verona Pharma Q2 2024 GAAP EPS $(0.11) Beats ...
Benzinga Newsdesk
Tuesday, July 30, 2024
Top 3 Health Care Stocks You May Want To Dump This Quarter
Avi Kapoor
Monday, July 22, 2024
Canaccord Genuity Maintains Buy on Verona Pha...
Benzinga Newsdesk
Monday, July 01, 2024
HC Wainwright & Co. Reiterates Buy on Verona ...
Benzinga Newsdesk
Friday, June 28, 2024
Truist Securities Maintains Buy on Verona Pha...
Benzinga Newsdesk
Thursday, June 27, 2024
Verona Pharma's Options Frenzy: What You Need to Know
Benzinga Insights
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
Vandana Singh
Canaccord Genuity Maintains Buy on Verona Pha...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Verona P...
Benzinga Newsdesk
Wednesday, June 26, 2024
Trading Halt: Halt status updated at 5:25:00 ...
Benzinga Newsdesk
Verona Pharma Says FDA Approved Ohtuvayre (En...
Benzinga Newsdesk
Trading Halt: Halted at 4:57:21 p.m. ET - Tra...
Benzinga Newsdesk
Tuesday, June 25, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Monday, June 24, 2024
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Shanthi Rexaline
Thursday, June 13, 2024
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Verona ...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Maintains Buy on Verona P...
Benzinga Newsdesk
Thursday, May 09, 2024
Verona Pharma Q1 2024 GAAP EPS $(0.04) Beats ...
Benzinga Newsdesk
Verona Pharma Announces $650M Strategic Finan...
Benzinga Newsdesk
Thursday, May 02, 2024
Verona Pharma To Present Additional Analyses ...
Benzinga Newsdesk
Tuesday, April 16, 2024
Piper Sandler Maintains Overweight on Verona ...
Benzinga Newsdesk
Monday, March 04, 2024
HC Wainwright & Co. Reiterates Buy on Verona ...
Benzinga Newsdesk
Friday, March 01, 2024
Wedbush Reiterates Outperform on Verona Pharm...
Benzinga Newsdesk
Thursday, February 29, 2024
Earnings Scheduled For February 29, 2024
Benzinga Insights
Verona Pharma Q4 EPS $(0.02), Flat YoY, Cash ...
Benzinga Newsdesk
Show More
